Therefore, to determine how BAFF directly affects T cells without affecting B cells or without interference effect on other immune cells (such as APC, interleukins, and so on), we examined whether belimumab could modulate acute GVHD by transplanting only splenic CD4+ T cells using GVHD protocol 2. The gene discussed is TNFSF13B; the disease is acute graft versus host disease.